Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 18Withdrawn 3Terminated 3Not yet recruiting 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 137INDUSTRY 112NIH 22NETWORK 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 25Ovarian Neoplasms 23Breast Neoplasms 22Lung Neoplasms 19Lymphoma 18Carcinoma, Ovarian Epithelial 18Neoplasm Metastasis 14Colorectal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 12Sarcoma 12Head and Neck Neoplasms 12Urinary Bladder Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Central Nervous System Neoplasms 10Astrocytoma 10Rectal Neoplasms 9Multiple Myeloma 9Uterine Cervical Neoplasms 8Oligodendroglioma 8Mycosis Fungoides 8Fallopian Tube Neoplasms 8Adenocarcinoma of Lung 8Stomach Neoplasms 7Recurrence 7Melanoma 7Medulloblastoma 7Brain Neoplasms 7Sezary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

peginterferon alfa-2b 1cabozantinib 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × Carcinoma, Renal Cell × Clear all
NCT06377722 2024-04-26

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Fundacion Oncosur

Phase 2 Terminated
18 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00467077 2017-03-17

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

California Cancer Consortium

Phase 2 Terminated
21 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00318110 2016-07-26

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Center for International Blood and Marrow Transplant Research

Phase 2 Terminated
4 enrolled
Genitourinary

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡